CDKL5 and Angelman syndrome: The efficacy of VNS in some cases of CDKL5- or MECP2-related epilepsy, Angelman syndrome, and Ring chromosome 20 syndrome or in DRE of other monogenic etiologies (one case) have been previously reported (12–23).